Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
ROCKVILLE, Md. and SUZHOU, China, April 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, and HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today jointly announce that the New Drug Application ("NDA") for the...
Moneymax partners with FWD Life Insurance to empower Filipinos in making better financial decisions
FWD Life Insurance's diverse portfolio of insurance products are now available on Moneymax for easy purchase MANILA, Philippines, April 2, 2024 /PRNewswire/ -- Moneymax, the Philippines' largest personal finance marketplace for financial products and a subsidiary of MoneyHero Limited (NASDAQ: MNY), today announced its strategic partnership with FWD Life Insurance (FWD Philippines) to give Filipinos access to life insurance...
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY
HONG KONG and SHANGHAI, April 2, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today announced its annual results for the year ended 31 December 2023 (the "Reporting Period"). During the Reporting Period, the Group achieved a total revenue of RMB198.2 billion, representing a year-on-year increase of...
Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS
Pioneering biologics CDMO rapidly adopts Veeva Vault QMS to advance development and manufacturing operations BANGALORE, India, April 2, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Kemwell BioPharma, India's largest biologics contract development and manufacturing organization (CDMO), has swiftly implemented the Veeva Vault Quality Management System (QMS) across its development and manufacturing operations. With Vault QMS, Kemwell will be able to...
23WELL, THE health supplement brand on the watch
LOS ANGELES, April 2, 2024 /PRNewswire/ -- Just earlier last month, the highly anticipated Natural Products Expo West 2024 concluded successfully in Anaheim, CA. As one of the world's largest leading health and nutrition exhibition, it hosted more than 65,000 registered attendees and 3,000+ exhibiting companies. During the expo period, Andall Biosciences Inc., an American biotechnology company, had invited...
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification
- Lunit's AACR 2024 presentations to spotlight HER2 mutation insights and CNTN4's role in immunotherapy success, pioneering next-gen personalized treatment approaches, supported by the AI-powered Lunit SCOPE suite SEOUL, South Korea, April 1, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the...
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones
TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of a paper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investigators at the University of Tokyo and the University of British Columbia, the team describes the development of an approach to identify new...
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development
PROVIDENCE, R.I., April 1, 2024 /PRNewswire/ -- In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical characterization step in the candidate development process to ensure drug efficacy and safety in...
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
HONG KONG, April 1, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2023, along with recent business updates. Financial Highlights Revenue from continuing operations of US$21.7 million in the full year 2023, an...
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO
～Hidemasa's appointment bolsters Aculys' position as a leader in the field of CNS in Japan and Asia～ TOKYO, April 1, 2024 /PRNewswire/ -- Aculys Pharma, Inc. ("Aculys"), a clinical-stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions, today announces the appointment of Hidemasa Tanigaki as Chief Executive Officer and Representative Director, effective March 29th. Hidemasa has...
